5/8/2013

The Florida Legislature has passed a bill allowing pharmacists to use the same standards for substituting biosimilar drugs that apply to generic small-molecule drugs. Makers of brand-name biologic drugs have been lobbying state legislatures for restrictive policies on biosimilars substitution.

Related Summaries